The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
Self-citationCONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Kloos (Chair), R. T., Eng, C., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, J. F., Pacini, F., Ringel, M. D., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0403 · Cited by 1,357
Guidelines for investigating causality of sequence variants in human disease
MacArthur, D. G., Manolio, T. A., Dimmock, D. P., Rehm, H. L., Shendure, J., Abecasis, G. R., Adams, D. R., Altman, R. B., Antonarakis, S. E., Ashley, E. A., et al. (2014) · Nature · doi:10.1038/nature13127 · Cited by 1,224
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
SDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776
Self-citationvon Hippel–Lindau disease: A clinical and scientific review
Maher, E. R., Neumann, H. P., & Richard, S. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.175 · Cited by 729
SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Hao, H.-X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.-P., Kunst, H., Devilee, P., Cremers, C. W. R. J., Schiffman, J. D., Bentz, B. G., et al. (2009) · Science · doi:10.1126/science.1175689 · Cited by 702
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Self-citationPheochromocytoma: recommendations for clinical practice from the First International Symposium
Pacak, K., Eisenhofer, G., Ahlman, H., Bornstein, S. R., Gimenez-Roqueplo, A.-P., Grossman, A. B., Kimura, N., Mannelli, M., McNicol, A. M., & Tischler, A. S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0396 · Cited by 680
Self-citationSDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 650
Self-citationMutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 609
Self-citationPheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545
van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 538
Self-citationExome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino-Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-García, L. J., Letón, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 526
Pasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
Self-citationCameron, E., & Pauling, L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4538 · Cited by 476
Amar, L., Baudin, E., Burnichon, N., Peyrard, S., Silvera, S., Bertherat, J., Bertagna, X., Schlumberger, M., Jeunemaitre, X., Gimenez-Roqueplo, A.-P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0709 · Cited by 450
Self-citationA HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205119 · Cited by 397
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Castro-Vega, L. J., Buffet, A., De Cubas, A. A., Cascón, A., Menara, M., Khalifa, E., Amar, L., Azriel, S., Bourdeau, I., Chabre, O., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt639 · Cited by 397
Self-citationGermline mutations in TMEM127 confer susceptibility to pheochromocytoma
Qin, Y., Yao, L., King, E. E., Buddavarapu, K., Lenci, R. E., Chocron, E. S., Lechleiter, J. D., Sass, M., Aronin, N., Schiavi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.533 · Cited by 379
VON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS
Walther, M. M., Herring, J., Enquist, E., Keiser, H. R., & Linehan, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68171-2 · Cited by 361
Killian, J. K., Kim, S. Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., Quezado, M., Smith, W. I., Jahromi, M. S., Xekouki, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0092 · Cited by 356
Timmers, H. J. L. M., Chen, C. C., Carrasquillo, J. A., Whatley, M., Ling, A., Havekes, B., Eisenhofer, G., Martiniova, L., Adams, K. T., & Pacak, K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1248 · Cited by 348
Germline SDHB Mutations and Familial Renal Cell Carcinoma
Ricketts, C., Woodward, E. R., Killick, P., Morris, M. R., Astuti, D., Latif, F., & Maher, E. R. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn254 · Cited by 342
Schlisio, S., Kenchappa, R. S., Vredeveld, L. C. W., George, R. E., Stewart, R., Greulich, H., Shahriari, K., Nguyen, N. V., Pigny, P., Dahia, P. L., et al. (2008) · Genes & Development · doi:10.1101/gad.1648608 · Cited by 333
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Burnichon, N., Cascón, A., Schiavi, F., Morales, N. P., Comino-Méndez, I., Abermil, N., Inglada-Pérez, L., de Cubas, A. A., Amar, L., Barontini, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0160 · Cited by 331
Self-citationTimmers, H. J. L. M., Chen, C. C., Carrasquillo, J. A., Whatley, M., Ling, A., Eisenhofer, G., King, K. S., Rao, J. U., Wesley, R. A., Adams, K. T., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs188 · Cited by 283
Bardella, C., El‐Bahrawy, M., Frizzell, N., Adam, J., Ternette, N., Hatipoglu, E., Howarth, K., O'Flaherty, L., Roberts, I., Turner, G., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2932 · Cited by 281
Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1043 · Cited by 277
Self-citationPasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 273
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma
Taïeb, D., Timmers, H. J., Hindié, E., Guillet, B. A., Neumann, H. P., Walz, M. K., Opocher, G., de Herder, W. W., Boedeker, C. C., de Krijger, R. R., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2215-8 · Cited by 256
Germline SDHD mutation in familial phaeochromocytoma
Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G. R., Eng, C., Latif, F., & Maher, E. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04378-6 · Cited by 246
The Warburg effect is genetically determined in inherited pheochromocytomas
Favier, J., Brière, J.-J., Burnichon, N., Rivière, J., Vescovo, L., Benit, P., Giscos-Douriez, I., De Reyniès, A., Bertherat, J., Badoual, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007094 · Cited by 232
Self-citationAyala-Ramirez, M., Chougnet, C. N., Habra, M. A., Palmer, J. L., Leboulleux, S., Cabanillas, M. E., Caramella, C., Anderson, P., Al Ghuzlan, A., Waguespack, S. G., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2356 · Cited by 212
Hadoux, J., Favier, J., Scoazec, J., Leboulleux, S., Al Ghuzlan, A., Caramella, C., Déandreis, D., Borget, I., Loriot, C., Chougnet, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28913 · Cited by 210
Self-citationLópez-Jiménez, E., Gómez-López, G., Leandro-García, L. J., Muñoz, I., Schiavi, F., Montero-Conde, C., de Cubas, A. A., Ramires, R., Landa, I., Leskelä, S., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0256 · Cited by 209
Eisenhofer, G., Huynh, T.-T., Pacak, K., Brouwers, F. M., Walther, M. M., Linehan, W. M., Munson, P. J., Mannelli, M., Goldstein, D. S., & Elkahloun, A. G. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00838 · Cited by 207
King, K. S., Prodanov, T., Kantorovich, V., Fojo, T., Hewitt, J. K., Zacharin, M., Wesley, R., Lodish, M., Raygada, M., Gimenez-Roqueplo, A.-P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6353 · Cited by 196
Self-citationHealth Supervision for Children With Neurofibromatosis
Hersh, J. H., & Committee on Genetics (2008) · Pediatrics · doi:10.1542/peds.2007-3364 · Cited by 184
MAX and MYC: A Heritable Breakup
Cascón, A., & Robledo, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3891 · Cited by 176
Welander, J., Andreasson, A., Juhlin, C. C., Wiseman, R. W., Bäckdahl, M., Höög, A., Larsson, C., Gimm, O., & Söderkvist, P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4375 · Cited by 173
Brière, J.-J., Favier, J., Bénit, P., Ghouzzi, V. E., Lorenzato, A., Rabier, D., Renzo, M. F. D., Gimenez‐Roqueplo, A., & Rustin, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi359 · Cited by 173
Self-citationSomatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Burnichon, N., Buffet, A., Parfait, B., Letouzé, É., Laurendeau, I., Loriot, C., Pasmant, É., Abermil, N., Valeyrie‐Allanore, L., Bertherat, J. Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds374 · Cited by 163
Self-citationCrona, J., Verdugo, A. D., Maharjan, R., Stalberg, P. L. H., Granberg, D. O., Hellman, P., & Björklund, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4257 · Cited by 160
van Hulsteijn, L. T., Dekkers, O. M., Hes, F. J., Smit, J. W. A., & Corssmit, E. P. M. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101192 · Cited by 160
Gimenez-Roqueplo, A.-P., Caumont-Prim, A., Houzard, C., Hignette, C., Hernigou, A., Halimi, P., Niccoli, P., Leboulleux, S., Amar, L., Borson-Chazot, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2975 · Cited by 159
Self-citationClinical and Genetic Characteristics of Patients with Neurofibromatosis Type 1 and Pheochromocytoma
Bausch, B., Borozdin, W., & Neumann, H. P. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmc066006 · Cited by 154
Rationale and Evidence for Sunitinib in the Treatment of Malignant Paraganglioma/Pheochromocytoma
Joshua, A. M., Ezzat, S., Asa, S. L., Evans, A. J., Broom, R. J., Freeman, M., & Knox, J. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1836 · Cited by 154
Loriot, C., Burnichon, N., Gadessaud, N., Vescovo, L., Amar, L., Libé, R., Bertherat, J. Y., Plouin, P., Jeunemaître, X., Gimenez‐Roqueplo, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3437 · Cited by 147
Self-citationLoss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors
Wagner, A. J., Remillard, S. P., Zhang, Y., Doyle, L. A., George, S., & Hornick, J. L. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.153 · Cited by 144
Pheochromocytoma — Death of an Axiom
Dluhy, R. G. (2002) · New England Journal of Medicine · doi:10.1056/nejm200205093461911 · Cited by 138
Jiménez, C., Cabanillas, M. E., Santarpia, L., Jonasch, E. W., Kyle, K. L., Lano, E. A., Matin, S. F., NUÑEZ, R. F., Perrier, N. D., Phan, A. T., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1972 · Cited by 133
Isocitrate Dehydrogenase Mutations Are Rare in Pheochromocytomas and Paragangliomas
Gaal, J., Burnichon, N., Korpershoek, E., Roncelin, I., Bertherat, J. Y., Plouin, P., de Krijger, R. R., Gimenez‐Roqueplo, A., & Dinjens, W. N. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2170 · Cited by 131
Self-citationPeitzsch, M., Prejbisz, A., Kroiß, M., Beuschlein, F., Arlt, W., Januszewicz, A., Siegert, G., & Eisenhofer, G. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012112 · Cited by 124
A Decade (2001-2010) of Genetic Testing for Pheochromocytoma and Paraganglioma
Buffet, A., Vénisse, A., Nau, V., Roncelin, I., Boccio, V., Pottier, N. L., Boussion, M., Travers, C., Simian, C., Burnichon, N., et al. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1304594 · Cited by 119
Self-citationThosani, S., Ayala‐Ramirez, M., Palmer, L. J., Hu, M. I.-N., Rich, T. A., Gagel, R. F., Cote, G. J., Waguespack, S. G., Habra, M. A., & Jiménez, C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1653 · Cited by 119
Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas
Welander, J., Larsson, C., Bäckdahl, M., Hareni, N., Sivlér, T., Brauckhoff, M., Söderkvist, P., & Gimm, O. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds402 · Cited by 119
Mosaicism inHIF2A-Related Polycythemia-Paraganglioma Syndrome
Buffet, A., Smati, S., Mansuy, L., Menara, M., Bras, M. L., Heymann, M., Simian, C., Favier, J., Murat, A., Cariou, B., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2600 · Cited by 105
Self-citationLong-Term Outcomes of Surgical Treatment for Hereditary Pheochromocytoma
Grubbs, E. G., Rich, T. A., Ng, C. S., Bhosale, P., Jiménez, C., Evans, D. B., Lee, J. E., & Perrier, N. D. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.10.012 · Cited by 96
Oh, D., Kim, T., Park, Y. S., Shin, S. J., Shin, S. H., Song, E., Lee, H. J., Lee, K., & Bang, Y. (2012) · Cancer · doi:10.1002/cncr.27675 · Cited by 95
Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families
Jasperson, K. W., Kohlmann, W. K., Gammon, A., Slack, H., Buchmann, L. O., Hunt, J. P., Kirchhoff, A. C., Baskin, H., Shaaban, A. M., & Schiffman, J. D. (2013) · Familial Cancer · doi:10.1007/s10689-013-9639-6 · Cited by 91
HIF2A mutations in paraganglioma with polycythemia.
Favier, J., Buffet, A., & Gimenez-Roqueplo, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1211953 · Cited by 73
Self-citationMinimally invasive cortical-sparing surgery for bilateral pheochromocytomas
Alesina, P. F., Hinrichs, J., Meier, B., Schmid, K. W., Neumann, H. P. H., & Walz, M. K. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0851-2 · Cited by 71
Qin, Y., Deng, Y., Ricketts, C. J., Srikantan, S., Wang, E., Maher, E. R., & Dahia, P. L. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt638 · Cited by 70
TMEM127Screening in a Large Cohort of Patients with Pheochromocytoma and/or Paraganglioma
Abermil, N., Guillaud-Bataille, M., Burnichon, N., Vénisse, A., Manivet, P., Guignat, L., Drui, D., Chupin, M., Josseaume, C., Affres, H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3360 · Cited by 67
Self-citationComprehensive Mutation Scanning of NF1 in Apparently Sporadic Cases of Pheochromocytoma
Bausch, B., Koschker, A., Faßnacht, M., Stoevesandt, J., Hoffmann, M. M., Eng, C., Allolio, B., & Neumann, H. P. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0780 · Cited by 58
Oudijk, L., de Krijger, R. R., Rapa, I., Beuschlein, F., de Cubas, A. A., Tos, A. P. D., Dinjens, W. N. M., Korpershoek, E., Mančíková, V., Mannelli, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3879 · Cited by 56
Ladroue, C., Hoogewijs, D., Gad, S., Carcenac, R., Storti, F., Barrois, M., Gimenez-Roqueplo, A.-P., Leporrier, M., Casadevall, N., Hermine, O., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.044644 · Cited by 55
Self-citationThe Clinical Phenotype of SDHC-Associated Hereditary Paraganglioma Syndrome (PGL3)
Else, T., Marvin, M. L., Everett, J. N., Gruber, S. B., Arts, H. A., Stoffel, E. M., Auchus, R. J., & Raymond, V. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3853 · Cited by 55
Giubellino, A., Bullova, P., Nölting, S., Turková, H., Powers, J. F., Liu, Q., Guichard, S. M., Tischler, A. S., Grossman, A. B., & Pacák, K. (2013) · Endocrinology · doi:10.1210/en.2012-1854 · Cited by 50
Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors
Baysal, B. E. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.12.005 · Cited by 46
Patient With Malignant Paraganglioma Responding to the Multikinase Inhibitor Sunitinib Malate
Hahn, N. M., Rečková, M., Liang Cheng, C., Baldridge, L. A., Cummings, O. W., & Sweeney, C. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9380 · Cited by 45
Crona, J., Verdugo, A. D., Granberg, D. O., Welin, S., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2013) · Endocrine Connections · doi:10.1530/ec-13-0009 · Cited by 42
McInerney-Leo, A. M., Marshall, M. S., Gardiner, B., Benn, D. E., McFarlane, J., Robinson, B. G., Brown, M. A., Leo, P. J., Clifton-Bligh, R. J., & Duncan, E. L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12331 · Cited by 39
Bickmann, J. K., Sollfrank, S., Schad, A., Musholt, T. J., Springer, E., Miederer, M., Bartsch, O., Papaspyrou, K., Koutsimpelas, D., Mann, W. J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3486 · Cited by 30
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas—Case Report
Canu, L., Rapizzi, E., Zampetti, B., Fucci, R., Nesi, G., Richter, S., Qin, N., Giaché, V., Bergamini, C., Parenti, G., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4453 · Cited by 11
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Olsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J. A., Damasceno, A., Delles, C., Gimenez-Roqueplo, A.-P., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 939
Self-citationZou, Y., Palte, M. J., Deik, A. A., Li, H., Eaton, J. K., Wang, W., Tseng, Y.-Y., Deasy, R., Kost-Alimova, M., Dančík, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09277-9 · Cited by 887
Metadata
- Authors
- Favier, J., Amar, L., & Gimenez-Roqueplo, A.-P.
- Venue
- Nature Reviews Endocrinology
- Published
- 2014-11-11
- Volume
- 11
- Issue
- 2
- Pages
- 101-111
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W1992412494
- Cited by
- 490
- References
- 87
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.